Study Reassures on Safety of Inhaled TiotropiumStudy Reassures on Safety of Inhaled Tiotropium

A major study on the safety of Boehringer Ingelheim's mist inhaler Spiriva (tiotropium) for chronic lung disease has found it does not increase the risk of early death, in contrast to an earlier analysis published two years ago. Reuters Health Information

Source: Medscape Medical News Headlines - September 9, 2013 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news